These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28642310)

  • 1. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD.
    Naz S; Kolmert J; Yang M; Reinke SN; Kamleh MA; Snowden S; Heyder T; Levänen B; Erle DJ; Sköld CM; Wheelock ÅM; Wheelock CE
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28642310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers.
    Chen Q; Deeb RS; Ma Y; Staudt MR; Crystal RG; Gross SS
    PLoS One; 2015; 10(12):e0143937. PubMed ID: 26674646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD.
    Balgoma D; Yang M; Sjödin M; Snowden S; Karimi R; Levänen B; Merikallio H; Kaarteenaho R; Palmberg L; Larsson K; Erle DJ; Dahlén SE; Dahlén B; Sköld CM; Wheelock ÅM; Wheelock CE
    Eur Respir J; 2016 Jun; 47(6):1645-56. PubMed ID: 26965288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
    Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
    Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
    Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of 8-OHdG formation and hOGG1 induction in PBMCs for assessing oxidative DNA damage in the lung of COPD patients.
    Yang S; Wu H; Zhao J; Wu X; Zhao J; Ning Q; Xu Y; Xie J
    Respirology; 2014 Nov; 19(8):1183-90. PubMed ID: 25154311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lundbäck B; Lindberg A; Lindström M; Rönmark E; Jonsson AC; Jönsson E; Larsson LG; Andersson S; Sandström T; Larsson K;
    Respir Med; 2003 Feb; 97(2):115-22. PubMed ID: 12587960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.
    Kornmann O; Beeh KM; Beier J; Geis UP; Ksoll M; Buhl R;
    Respiration; 2003; 70(1):67-75. PubMed ID: 12584394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling detects biomarkers of protein degradation in COPD patients.
    Ubhi BK; Riley JH; Shaw PA; Lomas DA; Tal-Singer R; MacNee W; Griffin JL; Connor SC
    Eur Respir J; 2012 Aug; 40(2):345-55. PubMed ID: 22183483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress.
    Fratta Pasini AM; Ferrari M; Stranieri C; Vallerio P; Mozzini C; Garbin U; Zambon G; Cominacini L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1733-43. PubMed ID: 27555763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype.
    Yang M; Kohler M; Heyder T; Forsslund H; Garberg HK; Karimi R; Grunewald J; Berven FS; Nyrén S; Magnus Sköld C; Wheelock ÅM
    Respir Res; 2018 Mar; 19(1):39. PubMed ID: 29514663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease.
    Kohler M; Sandberg A; Kjellqvist S; Thomas A; Karimi R; Nyrén S; Eklund A; Thevis M; Sköld CM; Wheelock ÅM
    J Allergy Clin Immunol; 2013 Mar; 131(3):743-51. PubMed ID: 23146379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
    Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
    J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.
    Aydemir Y; Aydemir Ö; Şengül A; Güngen AC; Çoban H; Taşdemir C; Düzenli H; Şehitoğulları A
    Heart Lung; 2019; 48(6):566-569. PubMed ID: 31371032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics-based search for lung cancer markers among patients with different smoking status.
    Klupczynska-Gabryszak A; Daskalaki E; Wheelock CE; Kasprzyk M; Dyszkiewicz W; Grabicki M; Brajer-Luftmann B; Pawlak M; Kokot ZJ; Matysiak J
    Sci Rep; 2024 Jul; 14(1):15444. PubMed ID: 38965272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
    Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products in the skin are enhanced in COPD.
    Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
    Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
    Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.